Inventor · disambiguated record
Ana Carrizosa Anderson
Also filed as: ANDERSON ANA C · ANDERSON ANA CARRIZOSA
16 granted patents·16 pending applications·131 citations·filing 2007–2025
89Inventor score
Files withBROAD INST INC14BRIGHAM & WOMENS HOSPITAL INC12BRIGHAM & WOMENS HOSPITAL3DANA FARBER CANCER INST INC1KUCHROO VIJAY K1
Top patents by PatentIndex Score
32 records- 0197US9163087B2Bi-specific antibodies against TIM-3 and PD-1 for immunotherapy in chronic immune conditionsKUCHROO VIJAY K·Filed 2011·Granted Oct 20, 2015·111 cites·5 claims
- 0293US10934352B2Bi-specific antibodies against Tim-3 and PD-1 for immunotherapy in chronic immune conditionsBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Granted Mar 2, 2021·6 cites·17 claims
- 0392US9834607B2Bi-specific antibodies against Tim-3 and PD-1 for immunotherapy in chronic immune conditionsBRIGHAM & WOMENS HOSPITAL INC·Filed 2015·Granted Dec 5, 2017·10 cites·1 claims
- 0485US10822587B2T cell balance gene expression, compositions of matters and methods of use thereofBROAD INST INC·Filed 2015·Granted Nov 3, 2020·4 cites·4 claims
- 0578US2025223357A1Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditionsBRIGHAM & WOMENS HOSPITAL INC·Filed 2025·Application pending·0 cites
- 0672US2021332130A1Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditionsBRIGHAM & WOMENS HOSPITAL INC·Filed 2021·Application pending·0 cites
- 0761US12421557B2Methods for predicting outcomes and treating colorectal cancer using a cell atlasBROAD INST INC·Filed 2020·Granted Sep 23, 2025·0 cites·16 claims
- 0860US2015284459A1Methods for modulating immune responses during chronic immune conditions by targeting il-27 induced pathwaysBRIGHAM & WOMENS HOSPITAL·Filed 2013·Application pending·0 cites
- 0958US11957695B2Methods and compositions targeting glucocorticoid signaling for modulating immune responsesBROAD INST INC·Filed 2019·Granted Apr 16, 2024·0 cites·12 claims
- 1058US2020095284A1Modulation of the immune responseBRIGHAM & WOMENS HOSPITAL INC·Filed 2019·Application pending·0 cites
- 1157US12049643B2Methods and compositions for modulating cytotoxic lymphocyte activityBROAD INST INC·Filed 2018·Granted Jul 30, 2024·0 cites·19 claims
- 1257US11793787B2Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesisBROAD INST INC·Filed 2020·Granted Oct 24, 2023·0 cites·2 claims
- 1357US10513540B2Modulation of the immune responseBRIGHAM & WOMENS HOSPITAL INC·Filed 2013·Granted Dec 24, 2019·0 cites·8 claims
- 1456US11981922B2Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironmentDANA FARBER CANCER INST INC·Filed 2020·Granted May 14, 2024·0 cites·14 claims
- 1556US11897953B2Compositions and methods targeting complement component 3 for inhibiting tumor growthBROAD INST INC·Filed 2018·Granted Feb 13, 2024·0 cites·3 claims
- 1654US12447213B2Modulation of novel immune checkpoint targetsBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Granted Oct 21, 2025·0 cites·15 claims
- 1754US12036240B2Compositions and methods targeting complement component 3 for inhibiting tumor growthBROAD INST INC·Filed 2019·Granted Jul 16, 2024·0 cites·20 claims
- 1854US2021130438A1Pan-cancer t cell exhaustion genesBROAD INST INC·Filed 2020·Application pending·0 cites
- 1954US2019040154A1Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoringBRIGHAM & WOMENS HOSPITAL INC·Filed 2018·Application pending·0 cites
- 2053US11186825B2Compositions and methods for evaluating and modulating immune responses by detecting and targeting POU2AF1BROAD INST INC·Filed 2018·Granted Nov 30, 2021·0 cites·20 claims
- 2153US11180730B2Compositions and methods for evaluating and modulating immune responses by detecting and targeting GATA3BROAD INST INC·Filed 2018·Granted Nov 23, 2021·0 cites·20 claims
- 2251US2011059106A1Methods for modulating a population of myeloid-derived suppressor cells and uses thereofBRIGHAM & WOMENS HOSPITAL·Filed 2009·Application pending·0 cites
- 2350US12241053B2Modulation of novel immune checkpoint targetsBRIGHAM & WOMENS HOSPITAL INC·Filed 2016·Granted Mar 4, 2025·0 cites·17 claims
- 2450US2022105135A1Methods and compositions for the modulation of opioid signaling in the tumor microenvironmentBROAD INST INC·Filed 2021·Application pending·0 cites
- 2549US2017058026A1Methods for modulating immune responses during chronic immune conditions by targeting il-27 induced pathwaysBRIGHAM & WOMENS HOSPITAL INC·Filed 2016·Application pending·0 cites
- 2648US2019100801A1Compositions and methods for evaluating and modulating immune responses by use of immune cell gene signaturesBROAD INST INC·Filed 2018·Application pending·0 cites
- 2748US2021130776A1Methods and compositions for modulating suppression of lymphocyte activityBROAD INST INC·Filed 2018·Application pending·0 cites
- 2848US2010061992A1Therapeutic uses of tim-3 modulatorsBRIGHAM & WOMENS HOSPITAL·Filed 2007·Application pending·0 cites
- 2948US2025288613A1Compositions and methods targeting sat1 for enhancing anti-tumor immunity during tumor progressionTHE BRIGHAM AND WOMEN’S HOSPITAL INC·Filed 2025·Application pending·0 cites
- 3045US2021263012A1Methods and compositions for modulating immune responses and lymphocyte activityBROAD INST INC·Filed 2018·Application pending·0 cites
- 3145US2016215042A1Methods for modulating immune responses during chronic immune conditions by targeting metallothioneinsBRIGHAM & WOMENS HOSPITAL INC·Filed 2014·Application pending·0 cites
- 3244US2017107300A1Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoringBRIGHAM & WOMENS HOSPITAL INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →